US FDA approves antibiotic combination with new beta-lactamase inhibitor
The US Food and Drug Administration has approved a new intravenous antibacterial product, Avycaz, which contains ceftazidime and a new beta-lactamase inhibitor, avibactam.…
Published: 5 March 2015